EVA Air will be utilising Singapore tech company Affinidi’s digital credential verification solution in a pilot program with Singapore Changi Airport to verify passengers’ Polymerase Chain Reaction (PCR) test results for EVA’s Singapore to Taipei flights.
The airline plans to extend this service to flights from Malaysia and Indonesia to Taipei and is evaluating the introduction of digital systems on other routes based on trial outcomes.
EVA is actively pursuing the development and deployment of digital verification platforms as part of its unwavering commitment to safeguarding the health and safety of passengers and crew members.
Affinidi’s interoperable technology solution will enable airline ground staff to quickly and accurately determine the authenticity of PCR test results, including the name of the medical institution, date of the test and whether the passenger meets relevant policy requirements in their destination country.
“EVA upholds rigorous standards for safeguarding the health and safety of everyone traveling onboard our airline. We are pleased to be partnering Affinidi and Singapore Changi Airport on this digital verification platform trial which will offer greater peace of mind for our passengers, while ensuring the privacy of their health credentials,” said David Chen, Executive Vice President at EVA.
By using Affinidi’s digital verification solution, EVA expects to eliminate human errors stemming from individual interpretation of test results. This will not only improve the passenger experience at the airport, but also boost operational efficiency.
Glenn Core, CEO of Affinidi, said: “Affinidi is committed to working with the aviation industry in building an ecosystem solution to address the increasingly complex environment for international travel as countries look to re-open their borders. We look forward to partnering EVA Air on this trial and to bringing greater convenience and confidence to travelers as we work towards our shared goal of making international travel safer for everyone.”
